In individuals with obesity, increased adipose tissue leads to elevated aromatase activity and residual estrogen production, potentially undermining AI efficacy (Fig. 1) [10]. The gene discussed is CYP19A1; the disease is obesity due to melanocortin 4 receptor deficiency.